News, views and contacts from the global Pharmaceutical industry

Takeda: Press Releases

Make An Enquiry

Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohn's Disease in the EU Friday, March 08, 2013 by Takeda Takeda Pharmaceutical Company today announced that a marketing authorisation application (MAA) has been submitted to the European Medicines Agency (EMA) for vedolizumab, an...